Glaukos (GKOS) Earnings Date & Reports

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

GKOS is expected to report earnings to fall 12.52% to -34 cents per share on April 30

Q1'25

Est.

$-0.35

Q4'24

Missed

by $0.02

Q3'24

Beat

by $0.20

Q2'24

Est.

$-0.52

Q1'24

Missed

by $0.24

The last earnings report on February 20 showed earnings per share of -40 cents, missing the estimate of -37 cents. With 247.00K shares outstanding, the current market capitalization sits at 4.61B.

View a ticker or compare two or three

Compare

GKOS